Xi'an International Medical Investment Company Limited

SZSE:000516 Stock Report

Market Cap: CN¥9.0b

Xi'an International Medical Investment Future Growth

Future criteria checks 0/6

Xi'an International Medical Investment is forecast to grow earnings and revenue by 76.1% and 6% per annum respectively. EPS is expected to grow by 73.9% per annum. Return on equity is forecast to be -1.8% in 3 years.

Key information

76.1%

Earnings growth rate

73.92%

EPS growth rate

Healthcare earnings growth18.4%
Revenue growth rate6.0%
Future return on equity-1.78%
Analyst coverage

Low

Last updated27 May 2026

Recent future growth updates

No updates

Recent updates

Analysis Article • Mar 04

Xi'an International Medical Investment Company Limited's (SZSE:000516) 26% Jump Shows Its Popularity With Investors

Those holding Xi'an International Medical Investment Company Limited ( SZSE:000516 ) shares would be relieved that the...
Analysis Article • Jan 18

Xi'an International Medical Investment Company Limited's (SZSE:000516) P/S Is On The Mark

When close to half the companies in the Healthcare industry in China have price-to-sales ratios (or "P/S") below 1.5x...
Analysis Article • Nov 21

Xi'an International Medical Investment (SZSE:000516) Is Making Moderate Use Of Debt

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Oct 01

After Leaping 27% Xi'an International Medical Investment Company Limited (SZSE:000516) Shares Are Not Flying Under The Radar

Xi'an International Medical Investment Company Limited ( SZSE:000516 ) shareholders would be excited to see that the...
Analysis Article • Jul 16

Xi'an International Medical Investment (SZSE:000516) Is Carrying A Fair Bit Of Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Jun 20

Investors Still Waiting For A Pull Back In Xi'an International Medical Investment Company Limited (SZSE:000516)

Xi'an International Medical Investment Company Limited's ( SZSE:000516 ) price-to-sales (or "P/S") ratio of 2.5x may...
Analysis Article • Mar 25

Does Xi'an International Medical Investment (SZSE:000516) Have A Healthy Balance Sheet?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Analysis Article • Feb 28

Xi'an International Medical Investment Company Limited (SZSE:000516) Not Lagging Industry On Growth Or Pricing

When you see that almost half of the companies in the Healthcare industry in China have price-to-sales ratios (or...

Earnings and Revenue Growth Forecasts

SZSE:000516 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20284,77323N/A8551
12/31/20274,489-81N/A7411
12/31/20264,239-151N/A5901
3/31/20264,047-2551,1261,282N/A
12/31/20254,075-3131,0141,276N/A
9/30/20254,205-3369821,306N/A
6/30/20254,429-2456871,076N/A
3/31/20254,640-2565261,034N/A
12/31/20244,815-2544611,009N/A
9/30/20244,880-3584191,022N/A
6/30/20244,829-3205041,203N/A
3/31/20244,732-3995101,084N/A
12/31/20234,618-3683251,087N/A
9/30/20234,141-5721161,153N/A
6/30/20233,853-803591,074N/A
3/31/20233,465-823-650891N/A
1/1/20232,711-1,177-727461N/A
9/30/20222,786-1,064-940294N/A
6/30/20222,683-1,058-1,269176N/A
3/31/20222,594-1,068-832184N/A
12/31/20212,921-822-1,203456N/A
9/30/20212,583-41-1,096374N/A
6/30/20212,27330-1,174379N/A
3/31/20211,96452-1,401252N/A
12/31/20201,60745-1,29741N/A
9/30/20201,391-882-2,168-285N/A
6/30/20201,188-753-2,627-422N/A
3/31/20201,046-622-3,378-313N/A
12/31/2019991-404N/A-34N/A
9/30/2019896-68N/A128N/A
6/30/2019872-19N/A-554N/A
3/31/20191,1082,193N/A-622N/A
12/31/20182,0392,184N/A-772N/A
9/30/20182,9732,244N/A-496N/A
6/30/20183,6172,280N/A203N/A
3/31/20184,130152N/A424N/A
12/31/20174,060195N/A384N/A
9/30/20174,024190N/A335N/A
6/30/20173,984191N/A395N/A
3/31/20173,944214N/A415N/A
12/31/20163,931202N/A439N/A
9/30/20163,872260N/A362N/A
6/30/20163,866217N/A350N/A
3/31/20163,866197N/A260N/A
12/31/20153,900241N/A274N/A
9/30/20153,927328N/A262N/A
6/30/20153,960369N/A292N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000516 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 000516 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 000516 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 000516's revenue (6% per year) is forecast to grow slower than the CN market (16.8% per year).

High Growth Revenue: 000516's revenue (6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000516 is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/18 05:01
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Xi'an International Medical Investment Company Limited is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mujun ShenCitic Securities Co., Ltd.
Jiarui TangEverbright Securities Co. Ltd.
BangHao GengPing An Securities Co. Ltd.